New strategy for COVID-19 vaccination: targeting the receptor

$ 15.00

5 (726) In stock

COVID-19: Coronavirus replication, pathogenesis, and therapeutic

Not available in Canada: A look at COVID-19 vaccine tech from

PDF) Epitopes for a 2019-nCoV vaccine

PDF) Epigallocatechin gallate (EGCG) attenuates severe acute respiratory coronavirus disease 2 (SARS-CoV-2) infection by blocking the interaction of SARS-CoV-2 spike protein receptor-binding domain to human angiotensin-converting enzyme 2

Preclinical studies support Army's pan-coronavirus vaccine

A closer look at Canada's homegrown COVID-19 vaccine candidates

Vaccine-like mRNA Injection Can Be Used to Make CAR T Cells

Applications of genetic engineering in COVID-19 - ScienceDirect

PDF) Modern Paradigm Towards Potential Target Identification for Antiviral (SARS-nCoV-2) and Anticancer Lipopeptides: A Pharmacophore-Based Approach